The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
Jonathan M. Meyer1,2, Henry A. Nasrallah3, Joseph P. McEvoy4,5, Donald C. Goff6,7, Sonia M. Davis8, Miranda Chakos9, Jayendra K. Patel10, Richard S.E. Keefe11, T. Scott Stroup12, Jeffrey A. Lieberman13
1VA San Diego Healthcare System, United States
2Department of Psychiatry, University of California, San Diego, United States
3Psychiatry and Neuroscience, University of Cincinnati, 231 Albert Sabin Way, PO Box 670559 Cincinnati, OH 45267-0559, United States
4Department of Psychiatry and Behavioral Sciences, Duke University, United States
5Clinical Research, John Umstead Hospital, 1003 12th Street Butner, NC 27509, United States
6Department of Psychiatry, Harvard University, United States
7Freedom Trail Clinic, Lindemann Mental Health Center, 25 Staniford St., Boston, MA 02114, United States
8Biostatistics, Quintiles Inc., 5927 South Miami Blvd, Morrisville, NC 27560, United States
9Psychiatry, Neurobiologic Disorders Research, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 1203, Brooklyn, NY 11203, United States
10Psychiatry, Schizophrenia Research, University of Massachusetts Medical School, 361 Plantation Street, Worcester, MA 01605, United States
11Department of Psychiatry and Behavioral Sciences, Duke University, Box 3270, Duke University Medical Center Durham, NC 27710, United States
12Department of Psychiatry, University of North Carolina at Chapel Hill, Campus Box 7160, Chapel Hill, NC 27599-7160, United States
13Department of Psychiatry, Columbia University, Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Schizophrenia Research
Tập 80
9-18
Thông tin tác giả